About Kim O'Neill
Form D filings for Thunder Biotech from 2017 to 2024 list Kim O'Neill as executive officer and director.
Kim O'Neill first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Kim O'Neill in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kim O'Neill works with at each company, as listed on that company's latest Form D.
Thunder Biotech, Inc. · Form D, Feb 26, 2024
KM
Kent Misener
Director
JB
James Burgess
Executive officer
BM
Barry Mower
Director
JH
Jeff Hone
Chief Executive Officer and director
ST
Steven Tanner
Director
SP
Scott Peterson
Director
JN
Jeffrey Nelson
Director